Product Information
ATENOLOL-CHLORTHALIDONE 50-25 is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.2217 per EA under NDC 70954039010. Its NADAC has been published 223 times since Jun 29, 2022.
FDA first approved this application on Oct 25, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50; 25 mg/1; mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954039010
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ATENOLOL; CHLORTHALIDONEApproval Type
Generic (ANDA)
FDA Application
ANDA215560FDA Approved
10/25/2021
TE Code
AB
On Market Since
10/25/2021
Pharmacological Classes
Price Statistics
The NADAC for ATENOLOL-CHLORTHALIDONE 50-25 has been published 223 times since Jun 29, 2022, and over the history we have for it it has declined 40.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2217 per EA |
|---|---|
| All-time high | $0.3694 (Jul 13, 2022) |
| All-time low | $0.2217 (Sep 23, 2026) |
| 52-week high | $0.2866 |
| 52-week low | $0.2217 |
| Median price | $0.3051 |
| Average price | $0.3025 |
| Largest weekly change | -25.1% (Nov 20, 2024) |
| Weeks tracked | 223 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Atenolol and Chlorthalidone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Thiazide-like Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATENOLOL-CHLORTHALIDONE 50-25?
The current National Average Drug Acquisition Cost (NADAC) for ATENOLOL-CHLORTHALIDONE 50-25, manufactured by ANI Pharmaceuticals, Inc., is $0.2217 per EA (NDC 70954039010), effective Sep 30, 2026.
How has the price of ATENOLOL-CHLORTHALIDONE 50-25 changed over time?
Over the history we have for it, the NADAC for ATENOLOL-CHLORTHALIDONE 50-25 has declined 40.0%. It has been tracked across 223 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for ATENOLOL-CHLORTHALIDONE 50-25?
Since Jun 29, 2022, the NADAC for ATENOLOL-CHLORTHALIDONE 50-25 has ranged from a low of $0.2217 (Sep 23, 2026) to a high of $0.3694 (Jul 13, 2022), with a median of $0.3051 per EA.
Are there cheaper alternatives to ATENOLOL-CHLORTHALIDONE 50-25?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATENOLOL-CHLORTHALIDONE 50-25 in a comparable dosage form, but none are currently priced below it.
Who manufactures ATENOLOL-CHLORTHALIDONE 50-25?
ATENOLOL-CHLORTHALIDONE 50-25 (NDC 70954039010) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.